期刊文献+

上皮钙黏素和β-连接素在儿童肝细胞癌中的表达及其临床意义 被引量:3

Expression of E-cadherin and β-catenin in children with hepatocellular carcinoma and its clinical significances
原文传递
导出
摘要 目的探讨上皮钙黏素(E-cad)和β-连接素(β-cat)在儿童肝细胞癌中的表达及其与肿瘤病理特征和预后的关系。方法用免疫组化Envision法检测42例儿童肝细胞癌组织中E-cad和β-cat蛋白的表达情况,并分析其与临床病理指标及预后的关系。结果(1)42例患儿中,E-cad异常表达者30例,占71.4%;β-cat异常表达者28例,占66.7%。(2)儿童肝细胞癌直径〉5cm、低分化、无肿瘤包膜及有复发转移的患儿组的E—cad和β-cat异常表达率显著高于儿童肝细胞癌直径〈5cm、高分化、有肿瘤包膜及无复发转移的患儿组(P〈0.05)。(3)E—cad和β-cat正常表达组的生存期和累积生存率显著高于异常表达组(P〈0.05)。结论E-cad和β-cat在儿童肝细胞癌有较高的异常表达率,它们的异常表达与肿瘤细胞的分化程度和侵袭、转移能力有关,异常表达者肿瘤容易发生复发、转移,预后较差。 Objective To investigate the expression of E-caherin(E-cad)and β-catenin(β-cat) in children with hepatocellular carcinoma(HCC)and its relation to clinicopathological characteristics of the tumor and prognosis. Methods The expression of E-cad and β-cat was detected in 42 HCCs by immunohistochemical technique. The relation of the expression of E-cad and β-cat to the clinicopathological data and survival rates of children with HCC were evaluated. Results 1)E cad was aberrantly expressed in 30 patients(71.4 % )and B-cat in 28 patients(66.7% ). 2)The rates of aberrant expression of E-cad and β-cat were significantly higher in children with HCC of a tumor size larger than 5cm in diameter, poor differentiation and without tumor capsule than those of a tumor size of less than 5cm in diameter, well differentiation and with tumor capsule. The rates of aberrant expression of E-cad and β-cat were also significantly higher in children with recurrence or metastasis of HCC than those without (P〈0.05). 3)The median survival time and the cumulative survival rates of children with HCC having proper E-cad and β-cat expression was significantly higher than that in those with aberrant expression (P〈0.05). Conclusion The rates of aberrant expression of both E-cad and β-cat are high in children with HCC and they are correlated with tumor differentiation and the edibility of invasion and metasta- sis. Aberrant expression of E-cad and β-cat may indicate a high potential of recurrence or metastasis and poor prognosis.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2009年第2期117-120,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 肝细胞 儿童 上皮钙黏素 Β-连接素 Carcinoma, hepatocellular Child E-cadherin β-catenin
  • 相关文献

参考文献14

  • 1张法标,王义,丛文铭,孙延富,张树辉,姚晓平,吴孟超.儿童期及青春期肝细胞癌临床病理特点及影响术后生存率的多因素分析[J].中华小儿外科杂志,2006,27(1):1-5. 被引量:10
  • 2Bremnes RM, Veve R, Cabrielson E, et al. High-throughout tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol, 2002, 20: 2417-2428.
  • 3Chen HC, Chu RY, Hsu PN, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett, 2003, 201: 97-106.
  • 4Tanaka N, Odajima T, Ogi K, et al. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer, 2003, 89: 557-563.
  • 5Gamallo C, Palacios J, Suarez A,et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol,1993, 142: 983-987.
  • 6Papadavid E, Pignatelli M, Zakynthinos S, et al. Abnormal immunoreactivity of the E-cadherin/catenin(alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocyticskin tumours. J Pathol, 2002,196:154-162.
  • 7Wei Y, Van Nhien JT, Prigent S, et al. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression,and clinical features. Hepatology, 2002,36 : 692-701.
  • 8Asayama Y, Taguchi Ki K, Aishima Si S, et al. The mode of tumour progression in combined hepatocellular carcinoma and eholangiocareinoma: an immunohistochemieal analysis of E- cadherin alpha-eatenin and beta-catenin. Liver, 2002, 22: 43- 50.
  • 9Ihara A, Koizumi H, Hashizume R, et al. Expression of epithelial cadherin and α- and β-Catenins in nontumoral livers and hepatocellular carcinomas. Hepatology, 1996, 23 : 1441-1447.
  • 10Yamaoka H, Ohtsu K, Sueda T, et al. Diagnostic and prognostic impact of beta catenin alterations in pediatric liver tumors. OncolRep, 2006, 15: 551-556.

二级参考文献8

  • 1樊嘉,汤钊猷,吴志全,周俭,周信达,马曾辰,钦伦秀,邱双健,余耀,黄成.门静脉微癌栓和肉眼癌栓对肝癌患者术后生存的影响[J].中华外科杂志,2005,43(7):433-435. 被引量:44
  • 2Moore SW, Millar A J, Hadley GP,et al. Hepatocellular carcinoma and liver tumors in South African children: A case for increased prevalence. Cancer, 2004, 101 : 642-649.
  • 3Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in U. S. children. Hepatology,2003,38:560-566.
  • 4Czauderna P. Adult type vs. Childhood hepatocellular carcinoma-are they the same or different lesions? Biology, natural history,prognosis and treatment. Med Pediatr Oncol. 2002, 39: 519-523.
  • 5Cedrone A, Rapaccini GL, Pompili M. et ah Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver, 1996,16:94-98.
  • 6Giannelli G, Pierri F, Trerotoli P, et al. Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res, 2002,24 : 50-59.
  • 7Gifter V, Kalechman Y, Sredni B. Induction of subpopulation of suppressor cell by a single blood transfusion. Kidney Int, 1992,41 : 143-148.
  • 8吴孟超.原发性肝癌外科综合治疗的现状和展望[J].中华外科杂志,2004,42(1):13-15. 被引量:74

共引文献9

同被引文献16

  • 1Jiang Long,Zhen-Wei Lang,Hua-Guang Wang,Tai-Ling Wang,Bao-En Wang and Si-Qi Liu Liver Research Center,Beijing Friendship Hospital, Capital Medical University,Beijing 100050,China,Department of Hepatology,Department of Pathology, Beijing Youan Hospital,Capital Medical University,Beijing 100069,China,Department of Pharmaceutical Affairs,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China,Department of Pathology,China-Japan Friendship Hospital,Beijing 100029,China,Beijing Genomics Institute,Chinese Academy of Science,Beijing Airport Industrial Zone B-6,Shunyi,Beijing 101300,China.Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected smal hepatocel ular carcinomas[J].Hepatobiliary & Pancreatic Diseases International,2010,9(3):296-305. 被引量:21
  • 2张法标,王义,丛文铭,孙延富,张树辉,姚晓平,吴孟超.儿童期及青春期肝细胞癌临床病理特点及影响术后生存率的多因素分析[J].中华小儿外科杂志,2006,27(1):1-5. 被引量:10
  • 3徐瑶,官阳,杨木兰.β-连环素和上皮钙粘连素在肝细胞癌中的表达及其意义[J].中国组织化学与细胞化学杂志,2006,15(3):272-275. 被引量:2
  • 4Patten LC, Belaguli NS, Baek MJ, et al. Serum response factor is alternatively spliced in human colon cancer[J]. J Surg Res, 2004, 121(1): 92-100.
  • 5Choi HN, Kim KR, Lee JH, et al. Serum response factor enhances liver metastasis of colorectal carcinoma via alter- ation of the E-cadherin/beta-catenin complex[J]. Oncol Rep, 2009, 21(1): 57-63.
  • 6Kim HJ, Kim KR, Park HS, et al. The expression and role of serum response factor in papillary carcinoma of the thyroid [J]. Int J Oncol, 2009, 35(1): 49-55.
  • 7Park MY, Kim KR, Park HS, et al. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial mesenchymal transition[J]. Int J Oncol, 2007, 31(6): 1309-1315.
  • 8Farra R, Dapas B, Pozzato G, et al. Serum response factor depletion affects the proliferation of the hepatocellular car- cinoma cells HepG2 and JHH6[J]. Biochimie, 2010, 92(5): 455-463.
  • 9Kwon CY, Kim KR, Choi HN, et al. The role of serum response factor in hepatocellular carcinoma: implications for disease progression[J]. Int J Oncol, 2010, 37(4): 837- 844.
  • 10Chelidonis G, Kavantzas N, Patsouris E, et al. DNA ploidy, E-cadherin, beta-catenin expression and their clinicopatho- logic significance in imprints of non-small cell lung cancer [J]. Anal Quant Cytol Histol, 2009, 31(5): 332-339.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部